Lower extremity peripheral artery disease (PAD) affects> 230 million adults worldwide and is
associated with increased risk of various adverse clinical outcomes (other cardiovascular …

SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions SCAI
consensus guidelines for device selection in femoral-popliteal arterial interventions Catheter …

Importance In a recent meta-analysis of randomized clinical trials, femoropopliteal artery
revascularization with paclitaxel drug-coated devices was associated with increased long …

Aims The best interventional strategy for the treatment of drug-eluting stent (DES) in-stent
restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up …

Background: Numerous studies have reported favorable outcomes using drug-coated
balloons (DCBs) for treatment of symptomatic peripheral artery disease of the superficial …

Coronary artery disease is the “first killer” in the world, while the classical treatment for this
disease is to implant stent. An ideal vascular stent should be nontoxic with self‐expanding …

1 Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and
risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis …

Objectives This study sought to evaluate the safety and effectiveness of the Ranger drug-
coated balloon (DCB)(paclitaxel dose density 2 μg/mm2) for treating superficial femoral …

Vascular stent implantation is an effective method for the treatment of artery stenosis, and
shape memory polymer (SMP) stents have become a promising stent type because of their …

Background The IN. PACT Global Study was an international prospective single-arm clinical
trial to evaluate the safety and effectiveness of a drug-coated balloon in the treatment of …